An ongoing shift in the cryptocurrency market continues to unfold as traditional assets like Bitcoin and Ethereum face sustained outflows, while some alternative tokens such as Solana attract fresh investor interest. Market participants remain cautious amid rising macroeconomic uncertainties, prompting risk-reduction strategies from institutional players. Despite turbulence in leading assets, newer blockchain projects with yield [...]An ongoing shift in the cryptocurrency market continues to unfold as traditional assets like Bitcoin and Ethereum face sustained outflows, while some alternative tokens such as Solana attract fresh investor interest. Market participants remain cautious amid rising macroeconomic uncertainties, prompting risk-reduction strategies from institutional players. Despite turbulence in leading assets, newer blockchain projects with yield [...]

Bitcoin & Ether ETF Outflows Hit Record Lows as SOL Inflows Surge Amid Market Turmoil

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Bitcoin & Ether Etf Outflows Hit Record Lows As Sol Inflows Surge Amid Market Turmoil

An ongoing shift in the cryptocurrency market continues to unfold as traditional assets like Bitcoin and Ethereum face sustained outflows, while some alternative tokens such as Solana attract fresh investor interest. Market participants remain cautious amid rising macroeconomic uncertainties, prompting risk-reduction strategies from institutional players. Despite turbulence in leading assets, newer blockchain projects with yield advantages are quietly drawing in capital, signaling evolving dynamics in the digital asset landscape.

  • Bitcoin and Ether ETFs see fifth consecutive day of net capital outflows, marking their steepest daily declines since mid-October.
  • Solana ETFs buck the trend with six consecutive days of inflows, attracting institutional interest due to yield prospects.
  • Market trends suggest macroeconomic factors like rising US dollar strength drive risk-off sentiment, influencing crypto ETF flows.
  • Solana’s momentum is attributed to both fresh capital and its narrative of speed, staking, and growth potential.
  • Experts warn that Solana’s positive flow remains niche, primarily driven by early adopters chasing yield amid broader risk aversion.

Cryptocurrency markets continue to grapple with shifting investor sentiment, as leading digital assets like Bitcoin and Ether experience persistent capital outflows. On Tuesday, both Bitcoin and Ethereum ETFs recorded their fifth straight day of withdrawals, with a combined total exceeding $800 million. Data from Farside Investors highlight that Bitcoin ETFs alone saw withdrawals topping $578 million — their sharpest single-day decline in months. Fidelity’s FBTC and BlackRock’s iShares Bitcoin Trust led this exodus. Similarly, Ether ETFs saw redemptions totaling approximately $219 million, extending a five-day redemptions streak that has erased nearly $1 billion since late October.

In contrast, Solana (SOL)-focused ETFs defied the broader market downturn, attracting nearly $15 million in net inflows and extending a six-day streak of positive flows. Notable products like Bitwise’s BSOL and Grayscale’s GSOL have benefited, as institutional traders rotate into the high-yield, fast blockchain. Such activity underscores a bifurcation in investor behavior amid macroeconomic jitters.

Institutions trim risk amid macro jitters

Vincent Liu, chief investment officer at Kronos Research, explained that the recent ETF redemptions are less about waning confidence in crypto and more about macroeconomic uncertainties. “Continuous redemptions reflect institutions trimming risk as leverage unwinds and macro jitters increase,” Liu told Cointelegraph. He pointed out that rising U.S. dollar strength and tightening liquidity conditions are the primary drivers behind these outflows, rather than a fundamental shift in crypto conviction.

He added that until liquidity conditions improve, capital rotation will likely persist, keeping traditional crypto assets under pressure, even as select projects like Solana continue to attract niche interest.

Solana’s story of growth and yield fidelity

Liu further noted that Solana’s recent influx of capital stems from both new flows and a compelling narrative centered around speed, staking, and growth prospects. This narrative resonates with early adopters seeking yield and expansion potential.

However, he cautioned that Solana’s ETF growth remains limited to a niche segment, primarily driven by investors looking for yield in a risk-off environment. “It’s a narrative-driven move by early investors, but the broader market remains cautious,” he warned.

Despite the turbulence across traditional assets, these dynamics suggest a nuanced shift in institutional and retail crypto interest, highlighting the evolving landscape of blockchain investments amid macroeconomic headwinds.

This article was originally published as Bitcoin & Ether ETF Outflows Hit Record Lows as SOL Inflows Surge Amid Market Turmoil on Crypto Breaking News – your trusted source for crypto news, Bitcoin news, and blockchain updates.

Market Opportunity
Solana Logo
Solana Price(SOL)
$84.62
$84.62$84.62
-0.02%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09